Robert L. Ferris, MD, PhD | Authors


Lessons From Clinical Trial Setbacks Lead to Next Phase of Oncologic Advances

October 04, 2020

In the wake of the enthusiasm around cancer immunotherapy trial results—with several positive trials presented annually at each American Society of Clinical Oncology meeting in more and more diseases over several years—setbacks have served as a grim reminder that our work is not finished.

Educational Interactions Among Oncologists Remain a Subtle Loss During COVID-19 Pandemic

July 18, 2020

Exciting new knowledge and a more exquisite understanding of the role of tumor cell biology and the tumor microenvironment have driven the fields of precision oncology/genomics-based medicine and immuno-oncology/cancer immunotherapy.